So, just where can the aficionado of medical research discover and contribute, if the need and opportunity arises, to a quality resource hub? Well, one answer to that question is Oncotarget. The people who represent that name and their work product have a lot going for them and there is definitely substantive value being built. For a quick connection and glimpse at the current activities going on with this particular project, anyone can checkout Facebook, Twitter, YouTube, Google+ or Linkedin. And in the meantime, subscribing to TOC alerts is as simple as submitting an email address. Maximizing the impact and insight of research by way of the peer-review is what these professionals do.
On the tip of the iceberg, there are the members of the editorial board Carlo M Croce and Andrew Schalley who set a very strong and steady standard for contribution. They lead the best way possible, by example. The results yielded from the time spent gathering meticulous information is staggering, when one considers the multitudes of live affected in thousands of cities under the course of a decade. Academic research and development like that takes laser focus and a competent global vision to achieve. Not to mention, when handling research of the medical nature, the details have to be just so correct that years and years of effort are not just dismissed as so much overcooked Christmas Ham.
For a keener understanding of the quality and structure of research and content drafting Oncotarget accepts, one can take a look at any research paper available to more clearly see what these people do. Take the paper “Atracurium Besylate and other Neuromuscular Blocking Agents Promote Astroglial Differentiation and Deplete Glioblastoma Stem Cells” for example. Of course, after the Abstract, Introduction and Results start the explaining, the numbers and charts fill any blanks that need to be visualized.
This research paper is all very on the level and scientifically sound. It even has sections for discussion, acknowledgements and materials and methods. Which is why most people, sadly, do not have plans to take a look at this particular piece of work material or anything else on its level. However, if one does have such an interest, there is far more food for thought were that comes from. And, it is all complements of Impact Journals LLC. Oncotarget, which is published by Impact Journals